Our Perspective
The published literature in hepatic parenchymal transection is heterogeneous. Some technologies have been shown to be superior in histologic models and animal studies, but randomized controlled trials or similar high-quality clinical data do not exist. At this point, no single energy source has shown to be superior to others, and it behooves the operator to be aware of the risks and benefits of the technology that they are using. Currently, many surgeons are using an “energy device”–clysis technique in which they replace the Kelly clamp with hemostatic device as the crush–clamp device. This was originally used with harmonic focus and was described as focus-clysis but is being used with other devices.